AVT Natural Products Limited (AVTNPL) is a part of the A.V. Thomas Group, incorporated in 1986 and based in Chennai, India. The company is primarily engaged in the manufacturing, trading, and distribution of plant-based extracts and natural ingredient solutions globally, catering to the food, beverage, animal nutrition, and nutraceutical industries. AVT Natural Products Ltd was listed on January 10, 2007. Mr. Ajit Thomas serves as the Chairperson.
The company offers a diverse range of products, including:
- Marigold extracts for eye care, food coloring, and poultry pigmentation.
- Spice oleoresins and oils for food coloring and flavoring.
- Value-added teas, such as decaffeinated and instant teas.
- Animal health and nutrition products.
- Agricultural crop inputs and Rosemary extract.
AVTNPL serves various industries, including food and beverage, cosmetics and personal care, animal nutrition and health, human nutrition, and crop science. The company has established a significant global presence with wholly-owned subsidiaries, AVT Natural Europe Ltd. and AVT Natural S.A. De C.v., and operates in the US, UK, Europe, and South East Asia, supplying high-quality natural extracts to domestic and international markets across 50 countries.
AVT Natural Products Ltd has a Market Capitalization of ₹1,005 Crore (as of current market data), with its stock traded on both NSE (AVTNPL) and BSE (scrip code 519105). The company's shares have shown volatility, with a 52-week high of ₹98.19 and a 52-week low of ₹51.41. Key financial ratios include a PE ratio of 22.42 and a PB ratio of 2.11 as of May 2025. The promoter holding of 75.0% demonstrates strong confidence and control by the promoters.
FY2024-25 Annual Results:
- Net Profit: Declined 9.50% to ₹48.23 crore in FY2024-25, compared to ₹53.29 crore in FY2023-24.
- Sales: Rose 7.50% to ₹556.04 crore in FY2024-25, compared to ₹517.26 crore in FY2023-24.
Q1 FY2024-25 Results:
- Net Profit: Rose 31.02% to ₹14.36 crore in Q1 FY2024-25, compared to ₹10.96 crore in Q1 FY2023-24.
- Sales: Rose 25.44% to ₹156.82 crore in Q1 FY2024-25, compared to ₹125.02 crore in Q1 FY2023-24.
- Q1 FY2024-25 Performance: Net Sales of ₹156.82 Crore, Net Profit of ₹14.36 Crore
- FY2024-25 Performance: Annual Revenue of ₹556.04 Crore, Annual Net Profit of ₹48.23 Crore
- Market Capitalization: ₹1,005 Crore (as of current market data)
- Promoter Holding: 75.0%
- PE Ratio: 22.42 (as of May 2025)
- PB Ratio: 2.11 (as of May 2025)
- Dividend Yield: 1.21%
- Debt to Equity: 1%
While the company has delivered a modest sales growth of 7.00% over the past five years and a low Return on Equity (ROE) of 13.4% over the last three years, its financial health shows promising aspects. AVTNPL maintains a healthy pre-tax margin of 14% and a good ROE of 11%. The company's debt-to-equity ratio of 1% signals a healthy balance sheet, indicating strong financial prudence.
Despite challenges, the company has shown resilience in recent quarters with improved profitability metrics. However, debtor days have increased from 85.4 to 103 days, an area for potential improvement.
AVT Natural Products Ltd has a consistent track record of rewarding its shareholders, maintaining a healthy dividend payout of 18.4% with a Dividend Yield of 1.21%. The audited FY2024-25 results approved a final 40% dividend, as declared on May 28, 2025, further underscoring the company's commitment to shareholder returns.
Mr. Ajit Thomas is the Chairman of AVT Natural Products Ltd, and Mr. P Mahadevan serves as the Company Secretary. The auditors for AVT Natural Products Ltd are Suri & Co.
The company faced a fine from both NSE and BSE for a delay in appointing a new Company Secretary after the resignation of the previous one, which momentarily impacted its compliance reputation. However, this compliance issue has since been addressed.
AVT Natural Products Limited's long-term rating has been upgraded to [ICRA]A+(Stable), with the short-term rating reaffirmed at [ICRA]A1. This reflects the company's stable financial position and strong creditworthiness, indicating a positive outlook from credit rating agencies.
The company is scheduled to hold its 39th Annual General Meeting (AGM) on August 13, 2025, where shareholders will review performance and discuss future strategic directions. AVTNPL continues to focus on expanding its global footprint in the growing natural ingredients and nutraceutical space, aiming to maintain operational efficiency and capitalize on industry opportunities despite recent challenges in sales growth momentum.
